106 related articles for article (PubMed ID: 2285451)
21. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
[TBL] [Abstract][Full Text] [Related]
22. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors.
Ramia S; Ramlawi F; Kanaan M; Klayme S; Naman R
Epidemiol Infect; 2005 Aug; 133(4):695-9. PubMed ID: 16050516
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
Sugg U; Schenzle D; Hess G
Transfusion; 1988; 28(4):386-8. PubMed ID: 3133848
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiological surveillance of infection by the human immunodeficiency virus (HIV) and of the acquired immunodeficiency syndrome (AIDS) in French Polynesia in 1991].
Gras C; Gendron Y; Philippon G; Chungue E; Laudon F; Sirven D; Renaud A; Lebras J; Cardines D; Prigent D
Med Trop (Mars); 1992; 52(1):51-6. PubMed ID: 1351239
[TBL] [Abstract][Full Text] [Related]
25. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
26. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
Jullien AM; Couroucé AM; Massari V; Maniez M; Finetti P; Brevière D; Girard M; Andréani T; Habibi B
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):668-72. PubMed ID: 8243482
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B core antibody (anti-HBc) in blood donors in the United States: implications for surrogate testing programs.
Kline WE; Bowman RJ; McCurdy KK; O'Malley JP; Sandler SG
Transfusion; 1987; 27(1):99-102. PubMed ID: 3643677
[TBL] [Abstract][Full Text] [Related]
28. HIV infection in intravenous drug abusers in Berlin: risk factors and time trends.
Stark K; Müller R; Guggenmoos-Holzmann I; Deininger S; Meyer E; Bienzle U
Klin Wochenschr; 1990 Apr; 68(8):415-20. PubMed ID: 2348645
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
McFarland W; Mvere D; Katzenstein D
AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
Karimi G; Zadsar M; Vafaei N; Sharifi Z; FalahTafti M
Virol J; 2016 Mar; 13():36. PubMed ID: 26944046
[TBL] [Abstract][Full Text] [Related]
31. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece.
Zervou EK; Dalekos GN; Boumba DS; Tsianos EV
Transfusion; 2001 May; 41(5):652-8. PubMed ID: 11346702
[TBL] [Abstract][Full Text] [Related]
32. [Hepatitis C virus and transfusion: policy regarding the donation and the donor. Groupe "Hépatites Virales" de la Société Nationale de Transfusion Sanguine].
Moncharmont P; Janot C; Boudart D; Cotte C; Couroucé AM; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M
Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):205-10. PubMed ID: 1329793
[TBL] [Abstract][Full Text] [Related]
33. Isolated anti-HBc among HIV-infected patients in Istanbul, Turkey.
Karaosmanoglu HK; Aydin OA; Nazlican O
HIV Clin Trials; 2013; 14(1):17-20. PubMed ID: 23372111
[TBL] [Abstract][Full Text] [Related]
34. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1.
Corona R; Prignano G; Mele A; Gentili G; Caprilli F; Franco E; Ferrigno L; Giglio A; Titti F; Bruno C
Epidemiol Infect; 1991 Dec; 107(3):667-72. PubMed ID: 1661241
[TBL] [Abstract][Full Text] [Related]
35. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
[TBL] [Abstract][Full Text] [Related]
36. The impact of AIDS on blood transfusion services in South Africa.
Grobbelaar BG
Med Law; 1992; 11(7-8):495-500. PubMed ID: 1302768
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
Seo DH; Whang DH; Song EY; Kim HS; Park Q
Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo].
Namululi BA; Guerrieri C; Dramaix MW
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094
[TBL] [Abstract][Full Text] [Related]
39. [Serum hepatitis B markers in blood donors in Venezuela. What do they mean?].
León G; Hernández T; García L; Maio A; Quiroz A; Gamboa M
Sangre (Barc); 1998 Oct; 43(5):385-91. PubMed ID: 9868330
[TBL] [Abstract][Full Text] [Related]
40. American Red Cross experience with routine testing for hepatitis B core antibody.
AuBuchon JP; Sandler SG; Fang CT; Dodd RY
Transfusion; 1989; 29(3):230-2. PubMed ID: 2493695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
